New research suggests that cancer survivors experiencing pain are more likely to use cannabis and cigarettes but less likely to consume alcohol than cancer survivors without pain.

Being obese at the time of MGUS diagnosis was associated with a 27% increase in the risk of progression to MM.

The FDA has granted fast track designation to amezalpat for the treatment of patients with hepatocellular carcinoma.